← Open Payments lookup

CHRISTINA NICHOLSON: Open Payments

NPI 1528485471 · URBANDALE, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,437 in 193 payments from 19 companies in 2025. Trend: 2023 $562 · 2024 $626 · 2025 $3,437

Food & beverage: $3,437
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.21$471
ABBVIE INC.31$460
Teva Pharmaceuticals USA, Inc.15$382
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)20$381
E.R. Squibb & Sons, L.L.C.11$182
Neos Therapeutics, LP11$176
Lundbeck LLC8$172
MDD US Operations, LLC16$161
Vanda Pharmaceuticals Inc.7$160
Almatica Pharma LLC13$146

Products named: REXULTI, VRAYLAR, CAPLYTA, UZEDY, AUSTEDO XR, COBENFY, Qelbree, FANAPT.

Industry payments across IA — which companies pay providers there.